Gu, L., Du, Y., Zhu, S., Liu, B., Wang, D., Wang, Y., He, L., Sun, Y., Tang, Q., He, Z. (2026). Adjuvant pembrolizumab in clear cell renal cell carcinoma with high recurrence risk: A multicenter real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16538